RESUMEN
BACKGROUND: Adipose derived stromal vascular fraction (SVF) contains a heterogeneous population of mononuclear cells, progenitor cells and about 1-10% are mesenchymal stromal cells. These cells are an ideal candidate for regenerative medicine for peripheral neuropathy. Leprosy is a disabling disorder with neuropathy, usually with consequences of permanent disability of the extremities. We conducted a preliminary study to evaluate the cell yield, its characteristics and clinical outcomes after SVF injections in four leprosy patients. METHODS: Four post leprosy patients were recruited and evaluated for sensory testing (warm detection, cold detection, vibration, pain and sensation) on the ulnar area of the hand. Liposuction was done and adipose tissue was processed into SVF with a closed system and injected to the ulnar area of the hand at the dorsal and palmar side. Evaluation of sensory testing was done after 3 days, 1 week, 1 month and 3 months following SVF injection. SVF was also characterized using flow cytometry, cell counting, sterility and presence of mycobacteria. RESULTS: The results showed that leprosy patients had a low count of mesenchymal cells and a high amount of CD34/CD45 positive cells. One patient was positive for mycobacteria from his adipose tissue and SVF. Sensory examination after SVF injection showed an improvement in temperature and pain sensation in the palmar and superficial branch. Meanwhile, touch sensation improved on the dorsal branch, and there was no improvement for vibration in all patients. CONCLUSIONS: The results showed that SVF had a potential to improve sensory loss in leprosy patients.
Asunto(s)
Lepra , Células Madre Mesenquimatosas , Enfermedades del Sistema Nervioso Periférico , Humanos , Tejido Adiposo , Enfermedades del Sistema Nervioso Periférico/terapia , Lepra/complicaciones , Lepra/terapia , DolorRESUMEN
PURPOSE: Grayscale ultrasonography when complemented with shear wave elastography helps in better evaluation of treatment response of leprosy neuropathy and in guiding appropriate management of the patient. There is limited literature regarding the use of shear wave elastography in ulnar nerve neuropathy. Our purpose was to evaluate the role of shear wave elastography in assessing stiffness changes within the ulnar nerve during treatment of leprosy. METHODS: This was a prospective study which included 30 patients diagnosed with leprosy neuropathy. Recruited patients were followed up, during the course of treatment, i.e. for 1 year. Serial ultrasonography of these patients was done at 0, 3, 6 and 12 months interval. RESULTS: Significant (P < 0.05) decrease in elastography parameters was seen in transverse imaging plane between first and third, as well as first and fourth visits (mean stiffness and velocity pretreatment ~ 25.78 ± 18 kPa and 2.74 ± 0.98 m/s, mean stiffness and velocity post-treatment 15.67 ± 5.89 kPa and 2.24 ± 0.428 m/s). Although elastography parameters decreased during these visits in the long-axis imaging plane, they were not found to be statistically significant. However, gross morphology and cross-sectional area of the nerve did not change significantly across visits. Interestingly, elastography values were higher in patients with neuritis, though not statistically significant. CONCLUSION: Shear wave elastography is a novel, upcoming modality in musculoskeletal imaging especially in the evaluation of peripheral neuropathy. It can act as an adjunct to grey-scale imaging, which can help in early diagnosis and in guiding treatment of leprosy neuropathy.
Asunto(s)
Diagnóstico por Imagen de Elasticidad , Lepra , Enfermedades del Sistema Nervioso Periférico , Infecciones de los Tejidos Blandos , Neuropatías Cubitales , Diagnóstico por Imagen de Elasticidad/métodos , Estudios de Seguimiento , Humanos , Lepra/complicaciones , Lepra/diagnóstico por imagen , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/diagnóstico por imagen , Enfermedades del Sistema Nervioso Periférico/terapia , Estudios ProspectivosRESUMEN
Neuropathy and related disabilities are the major medical consequences of leprosy, which remains a global medical concern. Despite major advances in understanding the mechanisms of M. leprae entry into peripheral nerves, most aspects of the pathogenesis of leprosy neuropathy remain poorly understood. Sensory loss is characteristic of leprosy, but neuropathic pain is sometimes observed. Effective anti-microbial therapy is available, but neuropathy remains a problem especially if diagnosis and treatment are delayed. Currently there is intense interest in post-exposure prophylaxis with single-dose rifampin in endemic areas, as well as with enhanced prophylactic regimens in some situations. Some degree of nerve involvement is seen in all cases and neuritis may occur in the absence of leprosy reactions, but acute neuritis commonly accompanies both Type 1 and Type 2 leprosy reactions and may be difficult to manage. A variety of established as well as new methods for the early diagnosis and assessment of leprosy neuropathy are reviewed. Corticosteroids offer the primary treatment for neuritis and for subclinical neuropathy in leprosy, but success is limited if nerve function impairment is present at the time of diagnosis. A candidate vaccine has shown apparent benefit in preventing nerve injury in the armadillo model. The development of new therapeutics for leprosy neuropathy is greatly needed.
Asunto(s)
Lepra , Neuritis , Enfermedades del Sistema Nervioso Periférico , Animales , Armadillos , Lepra/complicaciones , Lepra/diagnóstico , Lepra/terapia , Mycobacterium leprae , Neuritis/complicaciones , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/terapiaRESUMEN
Detecting enlargement of accessible nerves is very helpful in assessing patients with peripheral nerve disorders, as only a few types of neuropathy lead to nerve thickening. The three leading causes are leprosy, hereditary motor and sensory neuropathies (types 1 and 3) and chronic inflammatory demyelinating neuropathies. MRI, neurography and ultrasonography allow assessment of clinically inaccessible portions of deep-seated nerves, plexuses and roots. As a result, isolated proximal segment thickenings, as found in chronic inflammatory sensory polyradiculopathy, can now be better evaluated and managed. Similarly, focal nerve enlargements due to infection, inflammation, infiltration and neoplasm are being identified and treated effectively. We present a practical approach to the diagnosis and management of patients with enlarged peripheral nerves, plexuses and roots, including cranial nerves.
Asunto(s)
Manejo de la Enfermedad , Red Nerviosa/patología , Nervios Periféricos/patología , Enfermedades del Sistema Nervioso Periférico , Raíces Nerviosas Espinales/patología , Humanos , Hipertrofia/patología , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/terapiaRESUMEN
OBJECTIVE: To study the utility of nerve biopsy in providing diagnostic, therapeutic or prognostic information that aid in clinical management in elderly subjects with peripheral neuropathy. METHODS: Clinico-pathological data of 100 elderly subjects aged 65 and above with peripheral neuropathy who underwent nerve biopsy in the last decade (2002-2011) was reviewed. RESULTS: The study included 100 subjects (M:F 78:22). Mean age at biopsy and symptom duration was 69.62±4.8 years and 24.17±40.4 months, respectively. The most common pattern of was distal symmetric sensorimotor polyneuropathy (35%), followed by multiple mononeuropathy (29%) and asymmetric sensorimotor neuropathy (15%). The nerve biopsy was 'diagnostic' in 24%, (definite vasculitis in 12, leprosy in 10 and acute inflammatory demyelinating polyradiculoneuropathy in 2) and proved 'essential' or 'helpful' in therapeutic management in 81% subjects. In 60 (60%) patients, where a pre-biopsy aetiological diagnosis could be arrived at based on the available data, nerve biopsy confirmed the diagnosis in 29 of 60 (48.3%), and offered a new diagnosis in 25 (41.7%). A higher yield of biopsy was noted in subjects with asymmetric/multiple mononeuropathy compared with symmetric neuropathies (32.7% versus 17.7%). In 40 (40%) patients without a pre-biopsy aetiological diagnosis, nerve biopsy was 'essential' in 7 of 40 (17.5%) as it provided a definitive diagnosis (definite vasculitis: 5, leprosy: 2), and 'helpful' in 21 of 40 (52.5%) (ischaemic neuropathy: 10, possible vasculitis: 9, probable vasculitis: 2). CONCLUSION: Nerve biopsy aided in the detection of potentially treatable disorders and influenced patient management in a significant proportion of elderly subjects with peripheral neuropathy (81%), particularly in subset with undiagnosed neuropathies confirming that it's a useful tool in diagnosis of neuropathy in the elderly. With minor differences, the aetiological profile in our biopsied neuropathic elderly subjects may reflect the findings in other similar cohorts.
Asunto(s)
Envejecimiento/patología , Biopsia , Nervios Periféricos/patología , Enfermedades del Sistema Nervioso Periférico/patología , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Enfermedades del Sistema Nervioso Periférico/terapia , Valor Predictivo de las Pruebas , Pronóstico , Estudios RetrospectivosRESUMEN
BACKGROUND: Leprosy (Hansen's disease) is a chronic granulomatous infection caused by Mycobacterium leprae with peripheral neuropathy as cutaneous and neurological manifestations. Peripheral nerve regeneration may be stimulated by vascular endothelial growth factor and other growth factors (GFs) that have important roles in extracellular matrix regeneration. All of those GFs can be found in platelet-rich plasma (PRP) preparation. The effect of PRP injection in leprosy peripheral neuropathy has never been reported. MATERIALS AND METHODS: A double-blind, randomized, control clinical trial was conducted among 60 patients with leprosy peripheral neuropathy. They were randomized to receive either a 1-ml injection of PRP as treatment or a 1-ml injection of platelet-poor plasma (PPP) as control. Skin sensibilities were measured by two-point discrimination test (TPDT) and visual analog scale (VAS), which were taken before and two weeks after treatment. RESULTS: Perineural injection of PRP was shown to be significantly more effective than PPP (P < 0.05) either in VAS or TPDT measurements. In both groups, the patients had a tingling sensation at the time of injection that disappeared shortly after. CONCLUSION: This study shows that perineural PRP injection could promote improvement of peripheral neuropathy sensibility in patients with leprosy. More research is needed to better determine the effects of PRP in nerve regeneration.
Asunto(s)
Lepra/fisiopatología , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Enfermedades del Sistema Nervioso Periférico/terapia , Plasma Rico en Plaquetas , Células Receptoras Sensoriales/fisiología , Adulto , Método Doble Ciego , Femenino , Humanos , Inyecciones Intralesiones , Masculino , Persona de Mediana Edad , Plasma , Resultado del TratamientoRESUMEN
PURPOSE OF REVIEW: Infectious neuropathies are heterogeneous neuropathies with multiple causes. They still represent an important world health burden and some of them have no current available therapy. RECENT FINDINGS: Leprosy incidence has decreased by 50% during the last years, but leprosy-related neuropathies still cause severe disability. The pure neuritic leprosy is a diagnostic challenge that may require nerve biopsy or nerve aspiration cytology. The treatment itself may lead to a 'reversal reaction', which further causes injuries to the nerve. HCV-related neuropathies may be related or not to the presence of cryoglobulins. The absence of vasculitis, the most frequent form is a peripheral sensory neuropathy involving small nerve fibers, and more accurately diagnosed by pain-related evoked potentials. HIV-related neuropathy has become the major neurological complication of HIV infection. Both HIV-induced neuropathy and antiretroviral toxic neuropathy are clinically indistinguishable. The existence of an isolated chronic polyneuropathy due to Borrelia burgdorferi remains highly controversial. Lastly, an active infectious ganglioneuritis caused by varicella zoster virus, producing shingles, is the most frequent infectious neuropathy in the world and may cause various neurological complications. Zoster sine herpete remains frequently undiagnosed. SUMMARY: Recent data have improved our knowledge and diagnostic tools of infectious neuropathies. Treatment of the injured nerves is not yet available, and prevention and rapid diagnosis remain the main priorities for the clinician.
Asunto(s)
Infecciones/complicaciones , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Biopsia/métodos , Diagnóstico Precoz , Humanos , Infecciones/diagnóstico , Inflamación/complicaciones , Lepra/complicaciones , Lepra/diagnóstico , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/prevención & control , Enfermedades del Sistema Nervioso Periférico/terapiaRESUMEN
Leprosy still affects 240,000 persons every year in the world. It is a particularly common cause of neuropathy and severe disabilities in developing countries. With increasing migration, new cases of leprosy are regularly diagnosed in developed countries, where it still remains rare and so underestimated. Cutaneo-nevritic leprosy is the most frequent form of leprosy. It may be diagnosed by the clinical features and the cutaneous histology and bacteriology. Neuritic leprosy without obvious skin lesions is reported in 5 to 15% of leprosy patients. It must be suspected in persons from areas of endemic disease presenting with nerve thickening and associated nerve deficit. Nerve biopsy is essential for diagnosis. However search for bacilli in cutaneous samples may be of great help and avoid nerve biopsy. Acute and severe neuritis occurs during reactional states, reversal reaction (Type 1) and erythema nodosum leprosum (Type 2). Multidrug therapy is advocated. The treatment of acute neuropathy needs a supplementary medical and sometimes surgical treatment.
Asunto(s)
Lepra/clasificación , Lepra/diagnóstico , Lepra/microbiología , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/terapia , Humanos , Leprostáticos/uso terapéutico , Lepra/complicaciones , Lepra/patología , Lepra Lepromatosa/complicaciones , Lepra Lepromatosa/terapia , Lepra Tuberculoide/complicaciones , Lepra Tuberculoide/terapia , Mycobacterium leprae , Enfermedades del Sistema Nervioso Periférico/patología , Piel/patologíaRESUMEN
Leprosy (Hansen's disease) is a chronic granulomatous infectious disease, caused by Mycobacterium leprae, with cutaneous and neurological manifestations. Leprosy is very rare in Europe but some cases are reported, especially among people coming from endemic areas. Here, we report a case of Hansen's disease and emphasize the importance of a prompt diagnosis and treatment also in non-endemic areas.
Asunto(s)
Lepra/diagnóstico , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/terapia , Adolescente , Electromiografía , Humanos , Lepra/fisiopatología , Masculino , Neuronas Motoras/fisiología , Músculo Esquelético/inervación , Músculo Esquelético/fisiopatología , Conducción Nerviosa , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Senegal/etnología , Células Receptoras Sensoriales/fisiología , SiciliaRESUMEN
We report a 52 year-old woman with a past history of lepromatous leprosy (14 years prior to our first evaluation) who presented with progressive weakness and severe arm/leg pain. CSF analysis revealed elevated protein level with normal cell count. Skin and sural nerve biopsy showed no bacilli. Immunomodulatory treatment led to major improvement on clinical, CSF and electrodiagnostic grounds, but after one year of treatment, skin test revealed leprosy relapse. To our knowledge, this is the first report of a multifocal inflammatory neuropathy heralding leprosy relapse. Extended neurological work-up may be important in unexplained neuropathy progression after leprosy treatment.
Asunto(s)
Lepra Lepromatosa/fisiopatología , Debilidad Muscular/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Progresión de la Enfermedad , Femenino , Humanos , Inmunoterapia , Lepra Lepromatosa/líquido cefalorraquídeo , Lepra Lepromatosa/tratamiento farmacológico , Persona de Mediana Edad , Debilidad Muscular/líquido cefalorraquídeo , Debilidad Muscular/terapia , Enfermedades del Sistema Nervioso Periférico/líquido cefalorraquídeo , Enfermedades del Sistema Nervioso Periférico/terapia , Recurrencia , Piel/microbiología , Piel/patología , Nervio Sural/microbiología , Nervio Sural/patología , Factores de Tiempo , Resultado del TratamientoAsunto(s)
Personas con Discapacidad , Lepra/complicaciones , Enfermedades del Sistema Nervioso Periférico/etiología , Prejuicio , Personas con Discapacidad/psicología , Personas con Discapacidad/rehabilitación , Humanos , Lepra/epidemiología , Lepra/terapia , Enfermedades del Sistema Nervioso Periférico/psicología , Enfermedades del Sistema Nervioso Periférico/terapiaRESUMEN
The proportion of glomerulonephritis, often a sequence of arteriolitis, among the sequelae of Hansen's disease after the introduction of chemotherapy increased markedly in Japan and nullified that of once prevalent tuberculosis after 1960s. However, most significant aftermath of the disease for numbers of years in the past have been peripheral nerve injuries worldwide for which effective countermeasures are yet to be developed. In this brief autopsy cases study from 1960s to 1990s, we confirmed the presence of cases in which arteriolitis and resulted infarction of peripheral nerves and not M. leprae itself were shown to be the major cause of axonal damages. There were also cases in which the accumulation of the bacilli without vascular changes did not damage the axons. The cases as these could not be solitary but should be rather common in this time of chemotherapy. If so, the methods to reconstruct nerves and blood vessels by promoting those regeneration should be developed to cope with the situation for surgeon, assisted by pathologists.
Asunto(s)
Lepra/patología , Glomerulonefritis/etiología , Glomerulonefritis/terapia , Humanos , Lepra/complicaciones , Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/terapia , Vasculitis/etiología , Vasculitis/terapiaAsunto(s)
Enfermedades del Pie/terapia , Lepra/terapia , Enfermedades Óseas/etiología , Enfermedades Óseas/terapia , Deformidades Adquiridas del Pie/etiología , Deformidades Adquiridas del Pie/terapia , Enfermedades del Pie/etiología , Úlcera del Pie/etiología , Úlcera del Pie/terapia , Humanos , Lepra/complicaciones , Parálisis/etiología , Parálisis/terapia , Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/terapiaAsunto(s)
Lepra/fisiopatología , Mycobacterium leprae , Enfermedades del Sistema Nervioso Periférico , Humanos , Inmunoterapia , Enfermedades del Sistema Nervioso Periférico/microbiología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Enfermedades del Sistema Nervioso Periférico/terapia , Células de Schwann/microbiologíaAsunto(s)
Laminina/fisiología , Lepra/terapia , Mycobacterium leprae/fisiología , Enfermedades del Sistema Nervioso Periférico/microbiología , Enfermedades del Sistema Nervioso Periférico/terapia , Células de Schwann/microbiología , Humanos , Lepra/fisiopatología , Biología Molecular , Enfermedades del Sistema Nervioso Periférico/fisiopatologíaAsunto(s)
Lepra/complicaciones , Enfermedades del Sistema Nervioso Periférico/terapia , Animales , Humanos , Microcirugia , Músculo Esquelético/inervación , Músculo Esquelético/trasplante , Regeneración Nerviosa , Sistema Nervioso Periférico/fisiología , Sistema Nervioso Periférico/cirugía , Enfermedades del Sistema Nervioso Periférico/etiología , Procedimientos de Cirugía Plástica , Elastómeros de SiliconaAsunto(s)
Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/terapia , Elastómeros de Silicona , Lepra/complicaciones , Microcirugia , Músculo Esquelético/inervación , Músculo Esquelético/trasplante , Regeneración Nerviosa , Sistema Nervioso Periférico/cirugía , Sistema Nervioso Periférico/fisiologíaRESUMEN
Sixteen neuritic cases have been seen developing cutaneous lesions. These cutaneous lesions by and large appear within 4 months after the diagnosis of neuritic leprosy. Leprosy pathology in cutaneous lesions has been found ranging between indeterminate and borderline lepromatous group. Development of cutaneous lesions does not seem to be influenced by age, sex or number of nerves or lepromin status. Neither lesions seem to appear in any particular part of the body. Therapy, duration and type i.e. monodrug or multidrug, also does not seem to influence the development of cutaneous lesions in either way. It appears that neuritic cases with either very early (indeterminate) or with advanced multibacillary neural pathology may develop skin lesions. Skin lesion possibly appear following reversal reaction in skin. Cases with newly developed skin lesions well respond to standard therapy. Development of cutaneous lesions by neuritic cases possibly indicates towards the natural history of the disease, conforming to the hypothesis that leprosy is basically neural in inception and that all other forms emerge from it.
Asunto(s)
Lepra/patología , Enfermedades del Sistema Nervioso Periférico/etiología , Piel/patología , Adulto , Biopsia , Femenino , Humanos , Hipoestesia/etiología , Lepromina , Leprostáticos/uso terapéutico , Lepra/complicaciones , Lepra/terapia , Masculino , Persona de Mediana Edad , Nervios Periféricos/patología , Enfermedades del Sistema Nervioso Periférico/terapia , Piel/inervación , Piel/microbiologíaRESUMEN
In leprosy patients, the problems arising due to anaesthesia in the extremities have been outlined. The available modalities, some of them still experimental, for overcoming the handicap have been discussed.